Document is current
Any future updates will be listed below
-
Authors
Giacomelli, Andrea https://orcid.org/0000-0003-3685-4289
Riva, Agostino
Falvella, Felicia Stefania
Oreni, Maria Letizia
Cattaneo, Dario
Cheli, Stefania
Renisi, Giulia
Di Cristo, Valentina
Lupo, Angelica
Clementi, Emilio
Rusconi, Stefano
Galli, Massimo
Ridolfo, Anna Lisa
- License Information
-
More Information
Article History
Received: 13 December 2017
Accepted: 31 October 2018
First Online: 12 November 2018
Ethics approval and consent to participate
: The study was reviewed and approved by our ethics committee (Comitato Etico Interaziendale, Milano area 1); all subjects signed a dedicated informed consent.
: Not applicable.
: S.R. has received consultancy payments and speaking fee from Bristol-Myers Squibb, Gilead, ViiV Healthcare, Merck Sharp Dohme, ABBvie and Janssen. M.G. has received consultancy payments and speaking fee from Bristol-Myers Squibb, Gilead, ViiV Healthcare, Merck Sharp Dohme, ABBvie, Janssen and Roche.Preliminary data of this study were presented as poster presentation (PE10/15) at the 16th European AIDS conference, October 25–27, 2017 Milan, Italy.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
